MALIGNANT NEOPLASM OF PROSTATE
Clinical trials for MALIGNANT NEOPLASM OF PROSTATE explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASM OF PROSTATE trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASM OF PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can exercise supercharge cancer treatment? new study tests survival boost
Disease control Recruiting nowThis study is testing whether adding a personalized exercise program to standard radiation therapy helps men with advanced prostate cancer feel better, function better, and possibly live longer. Researchers will compare quality of life, fatigue, and physical function in 80 men wh…
Matched conditions: MALIGNANT NEOPLASM OF PROSTATE
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New combo aims to control prostate cancer without harsh hormone therapy
Disease control Recruiting nowThis study is testing whether a targeted drug called Pluvicto can be used instead of long-term hormone therapy when combined with radiation for men with locally advanced prostate cancer. The goal is to control the cancer while avoiding the difficult side effects of hormone therap…
Matched conditions: MALIGNANT NEOPLASM OF PROSTATE
Phase: PHASE1, PHASE2 • Sponsor: Angela Y. Jia, MD PhD • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New radiation attack on spread prostate cancer shows promise
Disease control Recruiting nowThis study is for men newly diagnosed with prostate cancer that has spread to a few other spots in the body. It tests if adding targeted radiation to those specific cancer spots, on top of standard hormone therapy and prostate treatment, helps control the disease better and for l…
Matched conditions: MALIGNANT NEOPLASM OF PROSTATE
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC